NAD+ Therapy Explained: Cellular Energy, Brain Health, and Anti-Aging
By Dr. Laeeq A. Butt, M.D. MBA · January 29, 2026
Nicotinamide adenine dinucleotide (NAD+) is a coenzyme present in every living cell. It is essential for mitochondrial ATP production, DNA repair through PARP enzymes, cellular signaling, and sirtuin activation, the same longevity pathways activated by calorie restriction.
NAD+ levels decline approximately 50% between age 20 and age 50. This precipitous drop impairs cellular energy metabolism, accelerates aging biomarkers, and increases susceptibility to metabolic disease, neurodegeneration, and chronic fatigue syndrome.
Supplementation with NAD+ precursors, particularly NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside), has demonstrated significant benefits in human clinical trials. Documented outcomes include improved insulin sensitivity, enhanced cognitive performance, better exercise capacity, reduced inflammatory markers, and improved sleep architecture.
Some patients benefit from intravenous NAD+ therapy, which delivers the coenzyme directly into circulation at concentrations oral supplementation cannot achieve. The infusion experience can be intense but often produces remarkable mental clarity and sustained energy.
At Mintlife Health, NAD+ therapy is never an isolated intervention. It is integrated into comprehensive longevity and performance protocols based on individual biomarker profiles and functional goals. We measure baseline NAD+ status, track improvements, and adjust dosing strategically. Your cellular energy is the foundation of everything else.